Circular RNA circHERC4 as a novel oncogenic driver to promote tumor metastasis via the miR-556-5p/CTBP2/E-cadherin axis in colorectal cancer.
Circular RNA circHERC4 as a novel oncogenic driver to promote tumor metastasis via the miR-556-5p/CTBP2/E-cadherin axis in colorectal cancer.
复制标题
环状RNA circHERC4作为一种新型致癌驱动因素,通过miR-556-5p/CTBP2/E-钙粘蛋白轴促进结直肠癌肿瘤转移
DOI:
10.1186/s13045-021-01210-2
复制
发表时间:
2021-11-15
影响因子:
28.5
通讯作者:
Liu L
中科院分区:
文献类型:
--
作者:
He J;Chu Z;Lai W;Lan Q;Zeng Y;Lu D;Jin S;Xu H;Su P;Yin D;Chu Z;Liu L
The main cause of death in colorectal cancer patients is metastasis. Accumulating evidences suggest that circRNA plays pivotal roles in cancer initiation and development. However, the underlying molecular mechanisms of circRNAs that orchestrate cancer metastasis remain vague and need further clarification. Two paired CRC and adjacent normal tissues were used to screen the upregulated circRNAs by circRNA-seq; then, cell invasion assay was applied to confirm the functional invasion-related circRNAs. According to the above methods, circHERC4 (hsa_circ_0007113) was selected for further research. Next, we investigated the clinical significance of circHERC4 in a large cohort of patients with CRC. The oncogenic activity of circHERC4 was investigated in both CRC cell lines and animal xenograft studies. Finally, we explored the molecular mechanisms underlying circHERC4 as a malignant driver. We demonstrated that circHERC4 was aberrantly elevated in CRC tissues (P < 0.001), and was positively associated with lymph node metastasis and advanced tumor grade (P < 0.01). Notably, the expression of circHERC4 was associated with worse survival in patients with CRC. Silencing of circHERC4 significantly inhibited the proliferation and migration of two highly aggressive CRC cell lines and reduced liver and lung metastasis in vivo. Mechanistically, we revealed that circHERC4 inactivated the tumor suppressor, miR-556-5p, leading to the activation of CTBP2/E-cadherin pathway which promotes tumor metastasis in CRC. CircHERC4 exerts critical roles in promoting tumor aggressiveness through miR-556-5p/CTBP2/E-cadherin pathway and is a prognostic biomarker of the disease, suggesting that circHERC4 may serve as an exploitable therapeutic target for patients with CRC. The online version contains supplementary material available at 10.1186/s13045-021-01210-2.
登录
查看更多内容
DOI:
10.1007/s00018-017-2688-5
发表时间:
2018-03
期刊:
Cellular and molecular life sciences : CMLS
影响因子:
--
作者:
Holdt LM;Kohlmaier A;Teupser D
通讯作者:
Teupser D
DOI:
10.1126/science.abc9359
发表时间:
2020-12-18
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Shi CY;Kingston ER;Kleaveland B;Lin DH;Stubna MW;Bartel DP
通讯作者:
Bartel DP
影响因子:
10.9
作者:
Dong B;Li S;Zhu S;Yi M;Luo S;Wu K
通讯作者:
Wu K
DOI:
10.1073/pnas.0830998100
发表时间:
2003-04-15
影响因子:
11.1
作者:
Grooteclaes, M;Deveraux, Q;Frisch, SM
通讯作者:
Frisch, SM
影响因子:
6
作者:
Geng, Yiting;Zheng, Xiao;Jiang, Jingting
通讯作者:
Jiang, Jingting